IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
HIV Disclosure and Medication Adherence, a Pilot Study (RSAD-VIH-11)
This study has been completed.
Sponsor:
Policlinique Médicale Universitaire
Collaborators:
Centre Hospitalier Universitaire Vaudois
Swiss HIV Cohort Study
Information provided by (Responsible Party):
Marie Schneider, Policlinique Médicale Universitaire
ClinicalTrials.gov Identifier:
NCT01621412
First received: May 31, 2012
Last updated: December 21, 2015
Last verified: December 2015
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The investigators believe that disclosure of HIV status could influence medication adherence. If disclosure leads to social support, adherence could be improved. This study purpose is to assess correlation between disclosure and medication adherence, and to describe people whose HIV status has been disclosed to.
| Condition |
|---|
| HIV Infection |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Cross-Sectional |
| Official Title: | HIV Disclosure and Medication Adherence, a Pilot Study |
Resource links provided by NLM:
Further study details as provided by Marie Schneider, Policlinique Médicale Universitaire:
Primary Outcome Measures:
- Patient Adherence [ Time Frame: 30 days before survey ]Electronic monitoring of adherence during 30 days before survey
Secondary Outcome Measures:
- Patient Adherence [ Time Frame: 90 days before survey ]Electronic monitoring of adherence during 90 days before survey
| Estimated Enrollment: | 120 |
| Study Start Date: | April 2012 |
| Study Completion Date: | June 2013 |
| Primary Completion Date: | June 2013 (Final data collection date for primary outcome measure) |
Pharmacists administer a questionnaire to each consecutive subject taking part in the adherence-enhancing program at the pharmacy of the Department of Ambulatory Care And Community Medicine in Lausanne. This questionnaire assesses disclosure, response to disclosure, and living situation.
Adherence is measured by electronic monitoring and pill count.
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
Patients enrolled in the adherence-enhancing program at ther pharmacy of Department of Ambulatory Care and Community Medicine in Lausanne
Criteria
Inclusion Criteria:
- HIV Infection
- Enrolled in the adherence-enhancing program
Exclusion Criteria:
- Inclusion visit
- Not french or english speaker
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01621412
Please refer to this study by its ClinicalTrials.gov identifier: NCT01621412
Locations
| Switzerland | |
| Policlinique Médicale Universitaire | |
| Lausanne, Vaud, Switzerland, 1011 | |
Sponsors and Collaborators
Policlinique Médicale Universitaire
Centre Hospitalier Universitaire Vaudois
Swiss HIV Cohort Study
Investigators
| Principal Investigator: | Marie-Paule Schneider, PhD | Policlinique Médicale Universitaire |
| Principal Investigator: | Aurélie Gertsch, PhD-Student | Policlinique Médicale Universitaire |
| Study Chair: | Olivier Bugnon, Professor | Policlinique Médicale Universitaire |
| Study Chair: | Matthias Cavassini, MD | Centre Hospitalier Universitaire Vaudois |
More Information
| Responsible Party: | Marie Schneider, Pharmacist, PhD, Policlinique Médicale Universitaire |
| ClinicalTrials.gov Identifier: | NCT01621412 History of Changes |
| Other Study ID Numbers: |
RSAD-VIH-2011 |
| Study First Received: | May 31, 2012 |
| Last Updated: | December 21, 2015 |
Keywords provided by Marie Schneider, Policlinique Médicale Universitaire:
|
Medication Adherence HIV infection Disclosure |
Additional relevant MeSH terms:
|
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |
ClinicalTrials.gov processed this record on September 21, 2017